COLD-PCR Enrichment of Rare Cancer Mutations prior to Targeted Amplicon Resequencing

Abstract

As cancer care shifts toward personalized intervention based on each patient's unique genetic abnormalities and tumor genome, we anticipate that COLD-PCR combined with NGS will elucidate the role of mutations in tumor progression, enabling NGS-based analysis of diverse clinical specimens within clinical practice.